Pharmaceuticals

Fentanyl Market Insights Report: Opportunities and Drivers 2030

February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the fentanyl market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Fentanyl Market’s size between 2026 and 2030?

The fentanyl market has demonstrated significant growth in recent years. It is projected to expand from $17.15 billion in 2025 to $18.17 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 5.9%. This historical expansion can be ascribed to several factors, including the increasing prevalence of chronic and cancer pain, a rise in postoperative surgeries, a growing geriatric demographic, the widespread adoption of injectable opioids, and the enhancement of hospital and clinical infrastructure.

The fentanyl market is anticipated to experience robust expansion in the coming years. By 2030, this market is projected to reach $23.8 billion, expanding at a compound annual growth rate (CAGR) of 7.0%. Factors driving this growth during the forecast period include the creation of new fentanyl formulations, the incorporation of AI in pain management strategies, a growing need for palliative care delivered at home, a heightened emphasis on opioid safety and regulatory measures, and the expansion of ambulatory surgical centers. Key trends anticipated for the forecast period encompass personalized approaches to pain management, innovative transdermal drug delivery methods, less invasive anesthesia procedures, opioid stewardship initiatives, and the advancement of new formulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Which Drivers Are Shaping Strategic Decisions In The Fentanyl Market?

The future expansion of the fentanyl market is anticipated to be fueled by the rising occurrence of chronic diseases. A chronic disease is defined as a medical ailment enduring for an extended duration, usually exceeding three months, and frequently lasting a lifetime. Fentanyl’s primary application in these conditions involves addressing severe, ongoing pain that has not been adequately managed by alternative treatments or interventions. For instance, the Australian Institute of Health and Welfare, an Australian government agency, reported in October 2025 that approximately 57,100 adults aged 25 and older experienced acute coronary events in 2023, equating to about 156 occurrences daily. Consequently, the growing incidence of chronic diseases is boosting the growth of the fentanyl market.

What Segment Categories Are Covered In The Fentanyl Market?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Trends Are Expected To Impact The Competitive Landscape Of The Fentanyl Market?

Major companies active in the fentanyl market are developing innovative offerings like Opvee and securing regulatory approvals to reach wider customer bases, increase sales, and generate higher revenue. Opvee (nalmefene) is a powerful opioid receptor blocker utilized for managing confirmed or suspected opioid overdoses caused by both natural and synthetic opioids, including fentanyl. For example, in May 2023, Indivior PLC, a US-based pharmaceutical company, obtained U.S. Food and Drug Administration approval for its Opvee nasal spray. This product operates by blocking opioid effects in the brain, which can aid patients who have recently overdosed in restoring normal respiration and blood pressure. Opvee is provided as a nasal spray, simplifying its administration during emergencies. It constitutes a vital component among the medications employed to counteract opioid overdoses and preserve lives.

Which Major Firms Are Strengthening Their Position In The Fentanyl Market?

Major companies operating in the fentanyl market are Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Fentanyl Market?

North America was the largest region in the fentanyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Fentanyl Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

Browse Through More Reports Similar to the Global Fentanyl Market 2026, By The Business Research Company

Fentanyl Market Report 2026

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795